A detailed history of Le Jeune Puetz Investment Counsel LLC transactions in Amgen Inc stock. As of the latest transaction made, Le Jeune Puetz Investment Counsel LLC holds 15,209 shares of AMGN stock, worth $4.01 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares
15,209
Previous 15,204 0.03%
Holding current value
$4.01 Million
Previous $3.99 Million 7.94%
% of portfolio
1.35%
Previous 1.53%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

BUY
$225.79 - $275.2 $1,128 - $1,376
5 Added 0.03%
15,209 $3.68 Million
Q4 2022

Jan 20, 2023

SELL
$229.03 - $291.01 $26,338 - $33,466
-115 Reduced 0.75%
15,204 $0
Q2 2022

Jul 21, 2022

BUY
$230.71 - $256.74 $206,485 - $229,782
895 Added 6.2%
15,319 $3.73 Million
Q1 2022

May 02, 2022

BUY
$219.27 - $242.57 $21,927 - $24,257
100 Added 0.7%
14,424 $3.49 Million
Q4 2021

Jan 31, 2022

BUY
$198.88 - $227.6 $87,507 - $100,144
440 Added 3.17%
14,324 $3.22 Million
Q3 2021

Oct 26, 2021

BUY
$212.27 - $248.7 $149,650 - $175,333
705 Added 5.35%
13,884 $2.95 Million
Q2 2021

Jul 27, 2021

SELL
$233.58 - $259.14 $23,358 - $25,914
-100 Reduced 0.75%
13,179 $3.21 Million
Q1 2021

Apr 26, 2021

BUY
$221.91 - $258.6 $49,929 - $58,185
225 Added 1.72%
13,279 $3.3 Million
Q4 2020

Jan 28, 2021

BUY
$216.38 - $257.67 $24,018 - $28,601
111 Added 0.86%
13,054 $3 Million
Q3 2020

Nov 03, 2020

BUY
$234.65 - $260.95 $11,732 - $13,047
50 Added 0.39%
12,943 $3.29 Million
Q2 2020

Aug 03, 2020

SELL
$197.81 - $242.74 $49,452 - $60,685
-250 Reduced 1.9%
12,893 $3.04 Million
Q1 2020

Apr 29, 2020

SELL
$182.24 - $241.7 $104,241 - $138,252
-572 Reduced 4.17%
13,143 $2.66 Million
Q4 2019

Jan 28, 2020

SELL
$189.21 - $243.2 $37,842 - $48,640
-200 Reduced 1.44%
13,715 $3.31 Million
Q3 2019

Oct 23, 2019

BUY
$174.11 - $208.62 $34,822 - $41,724
200 Added 1.46%
13,915 $2.69 Million
Q2 2019

Jul 29, 2019

BUY
$166.7 - $195.41 $12,502 - $14,655
75 Added 0.55%
13,715 $2.53 Million
Q1 2019

Apr 23, 2019

BUY
$180.87 - $203.88 $136,014 - $153,317
752 Added 5.83%
13,640 $2.59 Million
Q4 2018

Jan 30, 2019

BUY
$178.4 - $208.25 $137,368 - $160,352
770 Added 6.35%
12,888 $2.51 Million
Q2 2018

Jul 26, 2018

SELL
$166.05 - $186.51 $29,058 - $32,639
-175 Reduced 1.42%
12,118 $2.24 Million
Q1 2018

Apr 27, 2018

BUY
$169.43 - $198.0 $16,095 - $18,810
95 Added 0.78%
12,293 $2.1 Million
Q4 2017

Jan 31, 2018

SELL
$168.79 - $188.59 $16,879 - $18,859
-100 Reduced 0.81%
12,198 $2.12 Million
Q3 2017

Oct 20, 2017

BUY
$167.29 - $191.0 $2.06 Million - $2.35 Million
12,298
12,298 $2.29 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Le Jeune Puetz Investment Counsel LLC Portfolio

Follow Le Jeune Puetz Investment Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Le Jeune Puetz Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Le Jeune Puetz Investment Counsel LLC with notifications on news.